NCT07049328View on ClinicalTrials.gov

HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata

PHASE1RecruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

August 16, 2025

Primary Completion Date

July 16, 2026

Study Completion Date

December 15, 2026

Conditions

Alopecia Areata(AA)

Interventions

DRUG

HCW9302, an IL-2 fusion protein

Injection

Trial Locations (2)

33612

RECRUITING

James A. Haley Veterans' Hospital, Tampa

43210

RECRUITING

The Ohio State University Wexner Medical Center, Columbus

Sponsors

Lead Sponsor

All Listed Sponsors

lead

HCW Biologics

INDUSTRY